Gazelle Futures / The Center for Advanc… Pitch Deck Teardown

Gazelle Futures, in partnership with The Center for Advancing Innovation, presents a massive 55-slide deck that functions more as an ecosystem overview than a traditional startup pitch. The model focuses on 'High-Impact Gazelles'—startups built around proven, capital-efficient inventions from institutions like the NIH and NASA. The deck highlights successful portfolio companies like Oncolinx ($20MM valuation) and Circumvent Pharmaceuticals ($5MM valuation), both of which licensed NIH inventions. While the deck is heavy on institutional credibility and partnership logos (AstraZeneca, Johns Hop…

Key takeaways

• The company highlights a portfolio company, Oncolinx, which has an exclusive license to an NIH invention and a $20MM valuation (Slide 7).
• Angio360 Diagnostics LLC is cited as having a $20MM valuation with its first sale projected for 2017 (Slide 7).
• The deck leverages the massive scale of MedImmune (AstraZeneca's R&D arm) to demonstrate the potential for biologics, citing a pipeline of 120+ biologics (Slide 2).
• Academic credibility is established through a list of collaborations with institutions like University of Cambridge, UCSF, and Johns Hopkins (Slide 19).
• The strategy involves mining 40 years of NASA 'Spinoff' data and the 2015-16 NASA software catalog to find commercializable IP (Slides 36, 46).
• The 'Gazelle' model is defined by three pillars: Proven Capital Efficient Inventions, Startup Catalyst, and Seasoned Management (Slide 1).
• Circumvent Pharmaceuticals is presented as a success story with an orphan drug indication from the FDA and a $5MM valuation (Slide 7).
• The deck concludes without a specific dollar amount 'ask,' instead seeking strategic partnerships and advisors (Slide 55).

Frequently asked questions

What is the primary business model of Gazelle Futures?

Gazelle Futures operates as a 'startup catalyst' that identifies underutilized intellectual property from federal labs (like NIH and NASA) and academic institutions. They then run 'startup challenges' to recruit management teams and form new companies around this IP. The goal is to create 'Gazelles'—high-growth companies that drive both outsized financial returns and social impact through medical or technological breakthroughs.

How does the deck demonstrate traction?

Traction is shown through the success of specific companies formed under their model. Slide 7 lists three examples: Oncolinx ($20MM valuation, 20 agreements with pharma), Circumvent Pharmaceuticals ($5MM valuation, FDA orphan drug status), and Angio360 Diagnostics ($20MM valuation). These examples serve as proof-of-concept for their ability to license government inventions and turn them into valued private entities.

What role do NASA and the NIH play in this deck?

They are the primary sources of 'Proven Capital Efficient Inventions.' The deck highlights 40 years of NASA spinoffs and a software catalog containing thousands of programs across 15 categories (Slide 46). By positioning themselves as the bridge to this institutional IP, Gazelle Futures argues they are starting with technology that has already been de-risked by millions in federal funding.

Who is the target audience for this 55-slide presentation?

Given the lack of a specific funding 'ask' and the focus on 'Key Takeaways' like joining a race or mentoring a team (Slide 55), the deck appears targeted at institutional partners, government agencies, and high-net-worth individuals interested in impact investing or ecosystem building rather than traditional seed or Series A venture capitalists.

What are the most significant omissions in the deck?

The deck lacks a clear revenue model for Gazelle Futures itself. While it shows the valuations of the startups it helps create, it does not explain how the parent organization makes money (e.g., equity stakes, management fees, or licensing royalties). Additionally, there is no slide detailing the specific use of funds or a roadmap for the platform's expansion.

Gazelle Futures / The Center for Advancing Innovation pitch deck: the facts

Company

Gazelle Futures / The Center for Advancing Innovation

Year

2016

Stage

Growth / Ecosystem Building

Slides

55

Sector

Tech Transfer / Venture Studio

Deck type

Partnership / Ecosystem Overview

Outcome

Not stated

Headquarters

Washington D.C. area (based on 202 area code)

Gazelle Futures / The Center for Advancing Innovation pitch deck PDF

The full Gazelle Futures / The Center for Advancing Innovation deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Gazelle Futures / The Center for Advancing Innovation pitch deck was used for

This deck is a 2016 growth / ecosystem-building presentation titled “The Center for Advancing Innovation & Gazelle Futures: Investing in High-Impact Gazelles that Drive Outsized Returns & Social Impact,” used at the BIO International Convention (LI BIO) to position Gazelle Futures as the dedicated venture fund and CAI as the challenge-accelerator engine behind it. It explains CAI’s model of sourcing commercially viable inventions from federal agencies (e.g., NIH, NASA, DoD), running startup challenges to form teams and launch companies, and then having Gazelle Futures invest structured seed capital into select “gazelle” startups emerging from those programs. The fund is framed as a strategic vehicle to commercialize a large portfolio of de-risked IP, generate outsized investor returns, and create social impact by building new industries in areas like oncology, precision medicine, and space technologies. Public sources around 2015–2017 describe CAI’s track record of spinning out dozens of startups via challenges (e.g., Breast Cancer Startup Challenge, SPACE RACE) and indicate that Gazelle Futures is being built as the venture strategy and commercialization fund to inject capital int

Business model: Gazelle Futures LLC is described as a venture fund and commercialization vehicle associated with The Center for Advancing Innovation (CAI), a 501(c)(3) nonprofit that runs challenge-accelerator programs to commercialize federally funded inventions and spin out startups; Gazelle Futures focuses on early-stage, capital-efficient startups emerging from CAI’s portfolio of de-risked IP.

Founders

Rosemarie H. Truman

Headquarters

Bethesda, Maryland, United States

Industry: Venture capital / tech transfer-focused venture studio and accelerator for federally funded inventions

What the Gazelle Futures / The Center for Advancing Innovation deck got right

• Clear link to an existing pipeline of startups. The deck ties Gazelle Futures directly to CAI’s established challenge-accelerator programs, which by early 2017 were already credited in public sources with launching 58 startups and training more than 2,000 entrepreneurs, giving investors evidence of an operating pipeline rather than a purely hypothetical model.
• Differentiated access to de-risked federal IP. CAI and Gazelle Futures emphasize access to a large, curated portfolio of federally funded inventions from agencies like NIH and NASA, with tens of thousands of inventions screened and hundreds identified as commercially viable, presenting a differentiated and proprietary deal flow channel.
• Disciplined, ownership-focused seed strategy. The investment strategy outlines structured seed checks of approximately $1–2M per company, capital-efficient deployment aimed at market entry within 3–4 years, and maintaining meaningful or majority equity stakes with reserved follow-on capital, which is a well-articulated, investor-aligned approach.
• Use of concrete, high-profile examples. The deck showcases specific flagship programs and technologies, such as the SPACE RACE Startup Challenge and NASA’s RASSOR robotic excavator, illustrating tangible applications in areas like extraplanetary mining, disaster response robotics, and precision medicine, which can help investors visualize the opportunity set.
• External validation via partnerships and competitions. Public materials highlight CAI’s success in external competitions and collaborations (e.g., MassChallenge, NASA CASIS partnerships, oncology challenges), which provides third-party validation of the organization’s ability to attract partners and compete for high-profile opportunities.
• Compelling blend of impact and return narrative. The mission narrative combines outsized financial returns with social impact, particularly in oncology and global health, appealing to impact-oriented investors while remaining grounded in a portfolio and accelerator structure recognizable to traditional venture capital.

What could have been stronger

• No externally verified fund close or LP base identified. The deck promotes Gazelle Futures as a venture fund with a structured seed strategy, but publicly available sources do not evidence a closed fund size, named limited partners, or a specific capital raise associated with this 2016 deck, which may leave investors uncertain about the vehicle’s capitalization.
• Limited disclosure of realized financial outcomes. While CAI’s challenges and resulting startups are discussed in aggregate (e.g., number of startups launched and entrepreneurs trained), the deck and contemporaneous public materials provide limited quantified financial outcomes such as exits, portfolio IRR, or realized returns, making it difficult to assess economic performance beyond programmatic metrics.
• Dependence on government IP without fully articulated long-term defensibility. The model relies heavily on licensing and commercializing federally funded inventions from agencies like NIH and NASA, but external materials do not fully detail long-term IP access arrangements, competition with other licensees, or how proprietary advantages are maintained over time for fund-backed startups.
• Limited public detail on governance and nonprofit–for-profit alignment. CAI and Gazelle Futures operate at the intersection of a nonprofit (CAI) and a for-profit venture fund (Gazelle Futures), but public descriptions focus more on programmatic mission than on specific governance structures, decision rights, or potential conflicts of interest between the nonprofit and the fund, which sophisticated LPs typically scrutinize.

How an investor would read this deck

What draws attention

• Unique access to a large, curated portfolio of de-risked, federally funded inventions from agencies such as NIH and NASA via CAI’s challenge-accelerator platform, which could represent differentiated proprietary deal flow compared to typical venture funds.
• Evidence that CAI’s model has already produced a pipeline of startups: public communications in 2017 cite 58 startups launched and over 2,000 entrepreneurs trained through multiple NIH- and NASA-supported startup challenges, indicating the model is operational rather than hypothetical.
• The SPACE RACE and NASA-related inventions (e.g., RASSOR robotic excavator) illustrate a focus on frontier technologies with potentially large upside (e.g., extraplanetary mining, robotics), which may appeal to investors seeking exposure to high-impact, deep-tech opportunities.
• The emphasis on capital efficiency, structured seed investments of roughly $1–2M per company, and maintaining significant or majority equity positions is attractive to investors prioritizing ownership and disciplined capital deployment.
• The mission alignment between CAI and Gazelle Futures—combining commercialization of life-saving inventions with economic development—may appeal to investors with impact mandates or interest in public–private innovation ecosystems.

Risks that stand out

• If Gazelle Futures has not closed a substantial pool of committed capital, there is a risk that the model remains largely programmatic and dependent on grants or ad hoc funding rather than a fully capitalized venture fund, which could limit the ability to follow through on investments in the pipelin
• Commercializing federally funded IP may pose regulatory, bureaucratic, or contractual risks—such as complex licensing negotiations or changes in agency policies—that could slow down or constrain startup formation and scale-up.
• The strategy appears to involve concentrated exposure to a set of government-sourced inventions and challenge-derived teams; if the pipeline quality or team execution is weaker than anticipated, fund performance could be adversely affected with limited diversification options.
• Operating at the intersection of nonprofit challenge programs and a for-profit fund could create perceived or actual conflicts (e.g., selection of winners, allocation of IP, or economic participation), which may introduce governance and reputational risks if not transparently managed.

Questions this deck invites

• Is there any independently verifiable information (e.g., regulatory filings, LP letters, press releases) confirming that Gazelle Futures has closed on committed capital, and if so, what is the fund size, deployment timeline, and LP composit
• What are the detailed performance metrics of CAI-associated startups to date, including follow-on funding raised, valuations, exits or M&A events, and any realized or unrealized returns attributable to Gazelle Futures or its investment stra
• How are governance and economics structured between the nonprofit CAI and the for-profit Gazelle Futures (e.g., who controls IP access, how are conflicts of interest managed, and how are economics shared between CAI, Gazelle Futures, and fo
• What is the long-term IP strategy regarding rights to federally funded inventions (e.g., exclusivity terms, renewal conditions, competition with other licensees), and how does this strategy protect the defensibility and value of portfolio c
• How repeatable and scalable is the challenge-accelerator model beyond the early NIH and NASA programs, and what commitments or partnerships exist with additional agencies, universities, or corporate partners to sustain a robust pipeline of

What founders can take from the Gazelle Futures / The Center for Advancing Innovation deck

• Pairing a nonprofit challenge-accelerator (CAI) with a dedicated venture fund (Gazelle Futures) can be a compelling structure for investors when it demonstrably converts de-risked IP into investable startups, highlighting the value of tightly coupled programmatic sourcing and capital deployment.
• Access to a large, curated portfolio of federally funded inventions (e.g., tens of thousands of NIH and NASA technologies) can serve as a differentiated edge for a venture strategy, but it must be supported by clear IP rights, licensing terms, and examples of successful commercialization.
• Demonstrating a pipeline of launched startups and trained entrepreneurs, as CAI does through challenges like the Breast Cancer Startup Challenge and SPACE RACE, strengthens the credibility of a fund thesis centered on ecosystem-building rather than individual deals.
• Explicitly focusing on capital efficiency and majority or meaningful equity stakes in early-stage investments can appeal to investors seeking outsized returns, but it also requires strong governance mechanisms and the capacity to support portfolio companies through follow-on rounds.
• Positioning a fund as both impact-driven (e.g., cancer, global health, space safety) and returns-focused can attract mission-oriented LPs, yet it increases the need for rigorous data on both social outcomes and financial performance to satisfy diverse stakeholders.
• Anchoring a fund thesis around partnerships with federal agencies and prestigious programs (NIH, NASA, MassChallenge, etc.) shows the power of leveraging public-sector R&D for private-sector value creation, but also underscores the importance of diversifying partnerships and maintaining resilience a

Gazelle Futures / The Center for Advancing Innovation pitch deck: common questions

What is Gazelle Futures and how does it relate to The Center for Advancing Innovation?

Gazelle Futures LLC is a venture fund and commercialization strategy closely tied to The Center for Advancing Innovation (CAI), a nonprofit that runs challenge-based accelerators to commercialize federally funded inventions. CAI identifies promising IP from agencies like NIH and NASA, runs startup challenges to form founding teams, and Gazelle Futures is designed to invest in the most promising of those startups with structured seed capital while helping govern and mentor them.

How does the CAI / Gazelle Futures model work according to the deck?

The deck describes a “challenge-accelerator” model in which CAI sources commercially viable inventions from a large federal IP portfolio (tens of thousands of inventions screened), runs structured startup challenges, forms multidisciplinary startup teams, provides a 12‑month intensive accelerator curriculum, and guides teams to secure licenses, build business plans, and raise seed funding. Gazelle Futures then makes $1M‑scale structured seed investments into selected “gazelle” startups, taking meaningful or majority equity and reserving capital for follow‑on rounds.

What concrete examples of deal flow or programs does the deck highlight?

The deck and related materials highlight NASA’s SPACE RACE Startup Challenge, which commercializes NASA inventions such as the RASSOR robotic excavator, as a flagship example of CAI’s de-risked, capital-efficient space robotics pipeline. CAI has also run NIH-sponsored challenges like the Breast Cancer Startup Challenge, Neuro Startup Challenge, and Nanotechnology Startup Challenge in Cancer; by early 2017 CAI reported launching 58 startups and training over 2,000 entrepreneurs through these programs.

What is known about the specific fundraising round associated with this deck?

No public source located describes a closed external fundraising round specifically for Gazelle Futures (e.g., a named seed or fund close with amount and investors), so there is no verified round size, valuation, or investor list. The deck appears to position Gazelle Futures as a strategic fund being raised to invest $1–2M per company in CAI-associated startups, but any target fund size or LP commitments are not documented in public announcements.

Who are the key people behind Gazelle Futures and CAI?

Public information confirms that Rosemarie H. Truman is the Founder and CEO of CAI and is also listed as Founder, CEO, and General Partner/Owner of Gazelle Futures LLC; an entrepreneur-in-residence named Sourav Sinha is also associated with Gazelle Futures in at least one deck. However, beyond these names, no comprehensive public team list or detailed bios for other fund partners are documented in verified funding announcements or filings.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

• The Center for Advancing Innovation Partners with the Founder...
• The SPACE RACE Startup Challenge Announces 15 Winning Teams to Commercialize NASA Inventions
• FINAL PLENARY SPACE RACE SHORT apr 23 2016 (3)
• Confidential & Proprietary the Center for Advancing Innovation and Gazelle Futures - Do Not Distribute without Permission
• Gazelles, unicorns, and dragons battle cancer through the... - PMC
• Center for Advancing Innovation - Wikipedia
• Rosemarie Truman - Impact Investor | Growth Strategy
• Rosemarie Truman: Forever Upward

Gazelle Futures / The Center for Advancing Innovation pitch deck slides

What each slide of the Gazelle Futures / The Center for Advancing Innovation pitch deck says

Slide 1

Seasoned Efficient Management Inventions THE CENTER FOR ADVANC (NG NNOVATION GAZELLE FUTURES Investing in High-Impact Gazelles that Drive Outsized Returns & Social Impact Confidential & Proprietary the Center for Advancing Innovation and Gazelle Futures - Do Not Distribute without Permission

Slide 3

. . . The Problem: identifying the . . . best inventions and furthering R&D Invention Inability to Find Atl Disclosed and and Fund @ Licensed Funded - os : Reeaeh Potentially : Promising @ Move to translational research Patented | Inventions | © More funding in lab; science continues °° i ! © No funding in lab to continue ctes © Ne @ Withdrawn/terminated license CN = >) ® eo ! @ Terminated by inventor Pa o oo | = ‘® all, °° eo | ) oe | 8% oe ©_ ® : Le I Ce 0 ®C ® 0 Lo eX») ®! D = Translational cE so o of REE 5 o9 2 Prepared for LES- Confidential & Proprietary the Centér for Advancing Innovation and Gazelle Futures - Do Not Distribute without Permission

Slide 4

ao Center for Advancing Sieze the OPPORTUNITY #7 Innovation—Mission Due Diligence - Selecting Investments Gober Technologie: PROFANE: a i Ee + 6% inventions -> $5008 to $1.5T GDP Impact Select the Best Federally Funded Inventions & 80-95% Failure Rate Unique Challenge-Accelerator given IP & Talent Access: Commercialization Strategy + Derisked IP: 21 agreements across NASA, NIH, NCI, CDC, etc Startups & Industry 2 Abe * Talent: 85+ Serial Entrepreneurs, Industry, etc. Evolution: Maximize Commercial Potential * Derisked IP: More Federal Labs Operators & Management Talent « Disrupting the Venture architecture norms 4 Prepared for LES: Confidential & Pronriceary th Contr foi Advancing trails EUS

Slide 5

i w 45 W -— CAI's Challenge-Accelerator 12 Month Intensive & Disciplined Accelerator Training 10 commercially viable inventions O O 1 Partnership Planning }Srolrm ]I-eam a.n And Licensing Identify Challenge I i ClectInvention Agreements nvemilon 500-1000 i Iti- "'\ Letter of Intent - form teams Selection L as N disciplinary teams Elevator Speech O Mentorship Fnter MultiStartup teams paired with Tailored A Id-class, seasoned exec ini . Disciplinary Wore ! Training Business Plan & Startup Launch Teatns levelindustry experts Gurriculum o o td o License &raise seed funding Elevator Speech ' innerenne 2 minute video with Busmgss P}an and Finalists Selected SIARIUES executive summary Live Pitch C…

Slide 6

p Startup Challenge Journey y | COMMERCIALIZE TOP BOLT ON FUND 05 1 | y 1% OF INVENTIONS 06 EC R— NANOTECH CANCER CHALLENGE J (@ he EXTEND TO THE 2 13 STARTUPS. LELTY NASA SPACE RACE 04 a _ 15-20 STARTUPS 8 Se”; hh SE strazeneca BREAST CANCER. | CHALLENGE 'g 4 A SCALE CHALLENGE MODEL 2X po (liSIARIES NEURO STARTUP CHALLENGE 02 ONCOLIN: . 22 STARTUPS 6

Slide 8

SPACE RACE Challenge - Novel Deal Flow Example De-Risked, Capital Efficient NASA Robotics Invention RASSOR Robotic Excavator — . Overview: Rugged, lightweight, small, autonomous robot excavator used in sites such as high-risk or inaccessible mining, search and rescue, as well as disaster response applications Only invention to exploit extraplanetary mining industry; $200B to $1T of value in just one asteroid Portfolio of 24K+ inventions: 100+ commercially viable inventions space inventions; 300+ precision medicine Expanding portfolio to include patents and inventions from DoD, DoE, DARPA, Navy and other agencies Opportunity: develop world-changing technologies, create new industries and eco…

Slide 11

Team Progress i i ¥ MASS Winner of Breast Cancer Startup Challenge by the National Cancer P Institute (NCI) mc CHALLENGE Awarded grants from Avon Foundation for Women, NASA/Center for the Advancement of Science in Space (CASIS), and the Horizon TEDMED 2020 Program (UK) Winner of MassChallenge & MassBio 2014 Startup Accelerators Winner of the Rice Business Plan Competition Raised seed financing, currently raising a bridge round Partnered with 14 pharma partners all over the world Partnered with 6 academic labs all over the world Offices in Boston and London Closed Startup Exclusive Option License Agreement with the NCI thiel Showcases: TEDMED, World ADC Summit, Engage Forum Tokyo, W feHOWShi…

Slide text above is read directly from the Gazelle Futures / The Center for Advancing Innovation deck PDF embedded on this page.

Related fundraising guides (24)

• Yuzu Health Pitch Deck Teardown: A Masterclass in Market Education and Infrastructure Replacement
• EnergyX Pitch Deck Teardown: A Masterclass in Industrial Validation and Scientific Pedigree
• Arize AI Pitch Deck Teardown: A Masterclass in Category Creation and Market Timing
• Innovafeed Pitch Deck Teardown: A $250M Masterclass in Industrial Scale and Strategic Partnerships
• Cube Pitch Deck Teardown: A $30M Series B Masterclass in Narrative Simplicity
• Friday Finance Pitch Deck Teardown: A $20M Series A Built on Aggregation and Social Proof
• HMNC Brain Health Pitch Deck Teardown: A Precision Psychiatry Play for Depression
• Clutch Wallet Pitch Deck Teardown: A $800k Pre-Seed Bet on Web3 Inclusivity
• Kinnu Pitch Deck Teardown: A Masterclass in Social Proof and Product-Led Growth
• Handly Pitch Deck Teardown: A B2B2C Play for the €5 Trillion Craft Services Market
• CAMP4 Therapeutics Pitch Deck Teardown: A $100M Masterclass in Biotech Platform Validation
• Thematic Pitch Deck Teardown: Leveraging Creator Networks for Scalable Music Promotion
• Fictiv Pitch Deck Teardown: A $100M Series E Masterclass in Supply Chain Simplification
• Beam Dental Pitch Deck Teardown: A Masterclass in Structural Cost Advantage
• Heali Pitch Deck Teardown: Leveraging Clinical Validation to Secure a $3M Seed Round
• Eliyan Pitch Deck Teardown: Solving the Chiplet Interconnect Bottleneck for AI
• api.video Pitch Deck Teardown: A Developer-First Approach to $12M Series A
• Include Pitch Deck Teardown: Scaling Smart City Infrastructure Through Global Distribution
• Craft.io Pitch Deck Teardown: A $8M Series A Masterclass in Product-Led Narrative
• AgBiome Pitch Deck Teardown: A $116M Series D Masterclass in Platform Validation
• Hintsa Pitch Deck Teardown: A $5.2M Masterclass in High-Performance Wellness Branding
• Circles Pitch Deck Teardown: A $16.5M Series A Bet on Scalable Peer Support
• Orchid Pitch Deck Teardown: A Masterclass in High-Stakes Clinical Validation
• Groundcover Pitch Deck Teardown: Leveraging eBPF to Disrupt Cloud Observability Costs

Decks from the same year (1)

• 2016 pitch deck examples

Decks from the same region (1)

• US pitch deck examples

Browse companies alphabetically (1)

• Pitch decks from companies starting with G

More pitch deck teardowns (16)

• Lexop Pitch Deck Teardown: Digitizing the $2 Billion Legal Document Delivery Market
• Lexop Pitch Deck Breakdown: Digitizing the $2B Legal Document Delivery Market
• Lexyom Pitch Deck Teardown: A Minimalist Look at MENA Legal Tech Disruption
• Lexyom Pitch Deck Breakdown: Targeting the $20B MENA Legal Market with AI
• LHS Pitch Deck Teardown: A Vertically Integrated Cannabis Play in Florida
• Libeo Pitch Deck Breakdown: Solving the €25 Trillion B2B Payment Friction
• Liberare Pitch Deck Teardown: A $1M Pre-Seed Strategy for Adaptive Fashion
• Liberty Resources Pitch Deck Teardown: A Speculative Mining Play in the Bowen Basin
• Libra Pitch Deck Teardown: A Hyper-Local Dating Concept Built on Coffee Shop Partnerships
• Libridge Global Pitch Deck Teardown: A Cross-Border Freelance Marketplace Strategy
• Liefergrün Pitch Deck Teardown: The $12M Strategy for Decarbonizing the Last Mile
• Lifestyler Pitch Deck Teardown: A Text-Heavy Vision for Algorithmic Fitness Plans
• LifeToYou Pitch Deck Teardown: A Direct-to-Consumer Play for Australia’s Healthy Snack Gap
• Lifted Pitch Deck Breakdown: A Human-Centric Approach to Home Care Digitization
• Liftit Pitch Deck Teardown: Scaling Last-Mile Trucking Logistics Across Latin America
• LigFlat Pitch Deck Teardown: A Brazilian VoIP Play Focused on Transparency and Growth

Recently published pitch deck teardowns (12)

• AvatarOS Pitch Deck Teardown: Leveraging Founder Pedigree to Raise $7M for AI Digital Humans
• Being Health Pitch Deck Teardown: A $5.4M Bet on Integrated Mental Health and Novel Treatments
• Banyan Ventures Pitch Deck Teardown: The Operator-Led Strategy for AI Infrastructure
• Big Happy Pitch Deck Teardown: A Masterclass in High-Signal AdTech Traction
• Boom Pitch Deck Teardown: A Masterclass in Unit Economics and Strategic Investor Social Proof
• Brigad Pitch Deck Teardown: A Mission-Driven Approach to the €1,000bn Flexible Labour Market
• CAMP4 Therapeutics Pitch Deck Teardown: A $100M Masterclass in Biotech Platform Validation
• Cann Pitch Deck Teardown: Positioning Cannabis as a Mainstream Alcohol Alternative
• Catch+Release Pitch Deck Teardown: Solving the Legal Bottleneck of User-Generated Content
• Carta Healthcare Pitch Deck Teardown: Scaling Clinical Data Abstraction with Human-in-the-Loop AI
• Capalo AI Pitch Deck Teardown: Optimizing Virtual Power Plants with AI-Driven Trading
• Chef Robotics Pitch Deck Teardown: A Data-First Approach to Solving Food Labor Shortages

Fundraising library · Pitch deck examples · Investor directory · Founder database